As therapies grow more complex and regulatory requirements evolve, providers, pharmacies and patients need a supply chain that can keep pace, manage specialized therapies and support continuity of care.
McKesson is a vital part of the healthcare infrastructure, serving as a logistical and operational backbone of the U.S. healthcare system. Our modernized U.S. pharmaceutical distribution network supports more than 40,000 prescription and over-the-counter pharmaceutical products, including branded, generic and specialty therapies, delivered safely and reliably through advanced automation, digital enablement and the dedication of our employees who show up every day for the patients counting on us.
With innovative tools, efficient processes to help ensure the quality and efficacy of products, an integrated delivery network and strong relationships across the country, our U.S. Pharmaceutical and Medical-Surgical businesses help to make sure customers get the medications patients need — anytime, anywhere.
Providing generic, branded and biosimilar medications, as well as vaccines, specialty medications, over-the-counter medications and more to acute care settings, such as:
Supporting providers with specialty drug therapies, vaccines and generics for patient care in non-acute and specialty treatment centers, such as:
We provide an expansive portfolio of plasma-derived products, biologics and other specialty drugs for patients living with cancer and rare diseases.
Distributing infusible, oral and injectable specialty medications, including the latest biosimilars, with broad reach, availability and accuracy.
Offering a best-in-class approach to specialty drug delivery, with comprehensive support for distribution, access and advanced therapies.
Providing the convenience of accessing our large portfolio of pharmaceuticals on the same order as your medical-surgical supplies and lab products.
We help biopharma accelerate innovative therapy launches so providers can access them when and where patients need them most, demonstrated by a recently launched Alzheimer’s medication where we were the first to enable access for care teams.
McKesson Third-Party Logistics® (3PL) works with biopharma companies of all sizes to distribute new and existing therapies of all types, as well as offer comprehensive solutions that help mitigate risk and protect product integrity.
We partner with suppliers and manufacturers every day to ensure our customers and their patients have access to the most optimal inventory selection of pharmaceuticals and more.
Innovative and patented medications from leading pharmaceutical companies
Alternatives to brand-name drugs with the same active ingredients and efficacy
Medications for complex or chronic conditions, often requiring special handling or administration, including biologic therapies
A wide range of vaccines for disease prevention
Plasma-derived treatments
Cost-effective alternatives to biologic drugs that offer similar efficacy and safety profiles
Advanced therapies that use cells or genetic material to treat, modify or potentially cure complex diseases
Medications designed for rare diseases, addressing unmet needs in the pharmaceutical landscape
Non-prescription medications and health products for everyday health needs
With more than 190 years of experience, we have a proven track record of deep expertise in pharmaceutical distribution. This experience allows for continued innovation and development of services for our customers. Our purchasing, quality, transportation and distribution teams work daily on unique ways to provide benefits for our partners, customers and their patients.
Learn how we are preparing our operational processes and our customers for DSCSA implementation.
Discover our resilient healthcare supply chain —addressing drug shortages, disaster readiness and pandemic preparedness.
